A pathogenic variant in BRCA1 results in increased risk for development of breast cancer (up to 80% lifetime risk) and ovarian cancer (up to 40% lifetime risk) in females. A male with a pathogenic variant would have an increased risk of breast cancer and prostate cancer. The gene discussed is BRCA1; the disease is ovarian carcinoma.